Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?

Clinical and Experimental Immunology

Volumn 149, Issue 3, 2007, Pages 440-444

  Gomes Silva, A ^a   De Cassia Bittar R ^a   Dos Santos Nogueira, R ^a   Amato, V S ^b   Da Silva Mattos, M ^c   Oliveira Neto, M P ^c   Coutinho, S G ^a   Da Cruz, A M ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Clinical cure; IFN ; IL 10; Leishmania (Viannia) braziliensis; Regulatory immune responses

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEISHMANIA BRAZILIENSIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SKIN LEISHMANIASIS; SUPERNATANT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED;

EID: 34547869232     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03436.x     Document Type: Article

References (26)

1. Bacellar O, Lessa H, Schriefer A et al. Up-regulation of th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002 70 : 6734 40.
2. Faria DR, Gollob KJ, Barbosa J Jr. et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005 73 : 7853 9.
3. Scott P. Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res 2003 27 : 489 98.
4. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição- Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993 91 : 1390 5.
5. Coutinho SG, Oliveira MP, Da-Cruz AM et al. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp Parasitol 1996 84 : 144 55.
6. Da-Cruz AM, Bittar R, Mattos M et al. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin Diagn Lab Immunol 2002 9 : 251 6.
7. Follador I, Araújo C, Bacellar O et al. Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 2002 34 : E54 8.
8. Bottrel RLA, Dutra WO, Martins FA et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 2001 69 : 3232 9.
9. Toledo VPCP, Mayrink W, Gollob KJ et al. Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Mem Inst Oswaldo Cruz 2001 96 : 89 98.
10. Trinchieri G. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. J Exp Med 2001 194 : F53 7.
11. Carvalho EM, Correia Filho D, Bacellar O, Almeida RP, Lessa H, Rocha H. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am J Trop Med Hyg 1995 53 : 273 7.
12. Da-Cruz AM, Oliveira MP, De Luca PM, Mendonça SCF, Coutinho SG. Tumor necrosis factor-α in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1996 91 : 225 9.
13. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998 31 : 143 8.
14. Belkaid Y, Hoffmann KF, Mendez S et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001 194 : 1497 506.
15. Zajtchuk JT, Casler JD, Netto EM et al. Mucosal leishmaniasis in Brazil. Laryngoscope 1989 99 : 925 39.
16. Rocha PN, Almeida RP, Bacellar O et al. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 1999 180 : 1731 4.
17. Bosque F, Saravia NG, Valderrama L, Milon G. Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 2000 51 : 533 41.
18. Caldas A, Favali C, Aquino D et al. Balance of IL-10 and interferon-γ plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 2005 5 : 113 21.
19. Stober CB, Lange UG, Roberts MTM, Alcami A, Blackwell JM. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 2005 175 : 2517 24.
20. + monocytes are hallmarks of active human visceral leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 2006 146 : 124 32.
21. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA 1993 90 : 3442 6.
22. Bourreau E, Prévot G, Gardon J, Pradinaud R, Launois P. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J Infect Dis 2001 184 : 1628 30.
23. Bittar RC, Nogueira RS, Vieira-Gonçalves R, Ribeiro VP, Mattos MS, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania braziliensis. Mem Inst Oswaldo Cruz 2007 (in press).
24. -) αβ and γδ T cells from human patients with cutaneous leishmaniasis. Infect Immun 2006 74 : 6317 23.
25. + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005 174 : 7147 53.
26. + T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 2006 193 : 1313 22.